Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
Clinical trial NCT00004744 · COMPLETED
Trial details
- NCT number
- NCT00004744
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1993-02-01
- Primary completion
- 1998-09-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.